Location: Boston, MA
CIK: 0001346824 · Show all filings
Period: Q3 2013 (← Previous) (Next →)
Filing Date: Nov 14, 2013
Total Value: $958M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACAD | ACADIA PHARMACEUTICALS INC | 5,250,000 | $144M | 15.1% | $13.77 | +51.8% | Call | 004225108 |
| — | DYAX CORP | 10,418,379 | $71.47M | 7.5% | $3.46 | — | COM | 26746E103 |
| — | NOVAVAX INC | 20,800,000 | $65.52M | 6.8% | $2.24 | — | COM | 670002104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,035,510 | $55.91M | 5.8% | $13.77 | +51.8% | COM | 004225108 |
| — | THERAPEUTICSMD INC | 16,528,641 | $48.43M | 5.1% | $3.00 | — | COM | 88338N107 |
| INSM | INSMED INC | 2,983,319 | $46.57M | 4.9% | $10.68 | +18.9% | COM PAR $.01 | 457669307 |
| SGMO | SANGAMO BIOSCIENCES INC | 4,258,244 | $44.67M | 4.7% | $8.72 | +13.8% | COM | 800677106 |
| — | ACHILLION PHARMACEUTICALS IN | 14,457,061 | $43.66M | 4.6% | $5.68 | — | COM | 00448Q201 |
| BCRX | BIOCRYST PHARMACEUTICALS | 5,844,700 | $42.55M | 4.4% | $5.07 | 0.0% | COM | 09058V103 |
| — | NEWLINK GENETICS CORP | 1,840,294 | $34.56M | 3.6% | $19.72 | — | COM | 651511107 |
| PRTA | PROTHENA CORP PLC | 1,646,399 | $33.31M | 3.5% | $15.16 | +16.7% | SHS | G72800108 |
| SGMO | SANGAMO BIOSCIENCES INC | 3,000,000 | $31.47M | 3.3% | $8.72 | +13.8% | Call | 800677106 |
| — | XOMA CORP DEL | 6,915,525 | $31.05M | 3.2% | $3.66 | — | COM | 98419J107 |
| — | DERMA SCIENCES INC | 1,994,876 | $24.7M | 2.6% | $13.35 | — | COM PAR $.01 | 249827502 |
| — | SUNESIS PHARMACEUTICALS INC | 4,869,261 | $24.15M | 2.5% | $5.18 | — | COM NEW | 867328601 |
| — | KERYX BIOPHARMACEUTICALS INC | 2,391,261 | $24.13M | 2.5% | $7.47 | — | COM | 492515101 |
| — | HYPERION THERAPEUTICS INC | 902,858 | $23.59M | 2.5% | $22.00 | — | COM | 44915N101 |
| — | CHEMOCENTRYX INC | 3,045,380 | $16.93M | 1.8% | $5.56 | — | COM | 16383L106 |
| — | ACHILLION PHARMACEUTICALS IN | 5,500,000 | $16.61M | 1.7% | $5.68 | — | Call | 00448Q201 |
| — | BLUEBIRD BIO INC | 467,418 | $12.6M | 1.3% | $26.96 | — | COM | 09609G100 |
| — | ROCKWELL MED INC | 1,000,000 | $11.4M | 1.2% | — | — | Put | 774374102 |
| MYGN | MYRIAD GENETICS INC | 450,000 | $10.57M | 1.1% | $28.41 | 0.0% | COM | 62855J104 |
| OMER | OMEROS CORP | 1,055,311 | $10.29M | 1.1% | $4.61 | +29.3% | COM | 682143102 |
| — | KERYX BIOPHARMACEUTICALS INC | 1,000,000 | $10.09M | 1.1% | $7.47 | — | Call | 492515101 |
| — | AMPIO PHARMACEUTICALS INC | 1,325,566 | $9.942M | 1.0% | $7.50 | — | COM | 03209T109 |
| — | NEWLINK GENETICS CORP | 500,000 | $9.39M | 1.0% | $19.72 | — | Call | 651511107 |
| — | ENZO BIOCHEM INC | 3,348,029 | $8.437M | 0.9% | $2.08 | — | COM | 294100102 |
| — | MIRATI THERAPEUTICS INC | 551,723 | $8.359M | 0.9% | $15.15 | — | COM | 60468T105 |
| — | DYNAVAX TECHNOLOGIES CORP | 6,000,000 | $7.14M | 0.7% | $1.10 | — | COM | 268158102 |
| — | ONCOGENEX PHARMACEUTICALS IN | 763,332 | $7.076M | 0.7% | $9.80 | — | COM | 68230A106 |
| — | CORONADO BIOSCIENCES INC | 1,000,000 | $7.011M | 0.7% | — | — | Call | 21976U109 |
| PTCT | PTC THERAPEUTICS INC | 300,000 | $6.438M | 0.7% | $17.38 | 0.0% | COM | 69366J200 |
| — | ARROWHEAD RESH CORP | 879,561 | $5.005M | 0.5% | $2.00 | — | COM NEW | 042797209 |
| — | DYAX CORP | 500,000 | $3.43M | 0.4% | $3.46 | — | Call | 26746E103 |
| TGTX | TG THERAPEUTICS INC | 600,000 | $3.024M | 0.3% | $6.12 | 0.0% | COM | 88322Q108 |
| AGIO | AGIOS PHARMACEUTICALS INC | 70,000 | $1.957M | 0.2% | $27.61 | 0.0% | COM | 00847X104 |
| — | OCERA THERAPEUTICS INC | 215,999 | $1.83M | 0.2% | $8.47 | — | COM | 67552A108 |
| — | EPIZYME INC | 10,000 | $400K | 0.0% | $28.13 | — | COM | 29428V104 |
| — | SAVIENT PHARMACEUTICALS INC | 1,000,000 | $193K | 0.0% | $0.23 | — | NOTE 4.750% 2/0 | 80517QAA8 |